Feetsee Showcases Innovation at BIO International Convention 2025 in Boston

From June 16–19, 2025, Feetsee proudly participated in the BIO International Convention in Boston — one of the world’s premier events for biotechnology and health innovation. The event convened over 20,000 global innovators, researchers, and investors dedicated to advancing healthcare.

Feetsee Inc. CEO Rytis Zajanckauskas and CBDO Viktorija Lapė represented the Lithuanian delegation, highlighting the growing strength and visibility of Lithuania’s medtech ecosystem.

Throughout the conference, Feetsee presented its contactless medical device for early inflammation detection — an innovation designed to prevent diabetic foot ulcers, a serious complication that often develops silently before being diagnosed. Live demonstrations, investor meetings, and dynamic discussions with global health leaders made for a highly productive and energizing week.

We extend our gratitude to everyone who visited us and contributed to new connections. Boston has left us more inspired than ever — and ready to continue our mission of transforming diabetic foot care.